Fe + C
Fe + C, licence 80068087: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
- NPN or DIN-HM
- 80068087
- Status
- Inactive licence
- Licence date
- 30 March 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Fer: up to 300 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Fer: up to 300 mg a day according to the dosing instructions published by Health Canada, above the niveau de sécurité from EFSAEuropean Food Safety Authority. for adults (40 mg a day). Son dépassement ne permet pas, à lui seul, de caractériser un risque : l'EFSA n'a pas pu fixer de limite supérieure pour ce nutriment. Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
niveau de sécurité. EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Fer Source : Polysaccharide-iron complex | 150.0 mg | 300,000 µg |
| Vitamine C Source : Ascorbate de calcium | 50.0 mg | 100,000 µg |
Non-medicinal ingredients
Hypromellose, Cellulose microcristalline, Stéarate de magnésium, dérivé sodium-cuivre de la chlorophylline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | minimum: 1.0 Capsule ; maximum: 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Helps to form red blood cells and helps in their proper function. Helps to prevent iron deficiency (anaemia). Helps the body to metabolize fats and proteins. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in wound healing.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
If you are experience abdominal pain/soreness or the presence of blood in the stool, discontinue use and consult a health care practitioner. This product may aggravate existing peptic ulcer or other inflammatory conditions of the gastrointestinal tract (e.g. regional enteritis or ulcerative colitis). If you experience acute stomach pain and vomiting of blood immediately after taking this product, stop use and consult a health care practitioner. Prolonged use of high levels of iron without evidence or iron deficiency will result in iron overload causing a darkening of the skin, joint and bone pain, sexual dysfunction and/or multiple organ damage. May cause constipation, diarrhea, abdominal cramping, nausea, vomiting and discoloration of the stool.
- Précautions et mises en garde
Keep out of reach of children. There is enough drug in this package to seriously harm a child. Use only upon recommendation by a physician. If you are pregnant or breastfeeding, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80068087
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.